ALLMedicine™ Mumps Center

Feb 18th, 2021 - Mumps is classified as a class C infection disease in China, and the Chongqing area has one of the highest incidence rates in the country. We aimed to establish a prediction model for mumps in Chongqing and analyze its seasonality, which is import...

Feb 5th, 2021 - Background: Currently, children aged 6-9 years have the highest incidence rate of mumps in China. Although China has introduced a two-dose schedule of measles-mumps-rubella vaccine into routine immunization (at 8 months and 18 months), the inciden...

Feb 3rd, 2021 - Intralesional immunotherapy has been effectively used in the treatment of warts; however, comparative studies between different antigens are limited. To evaluate the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine co...

Feb 1st, 2021 - In a previous cohort study of 4-year-old Danish children, revaccination with the live measles-mumps-rubella vaccine (MMR) was associated with a 16% reduction in the rate of hospitalization lasting two days or longer for non-measles-mumps-rubella i...

Jan 28th, 2021 - Intralesional immunotherapy using different types of antigens is considered an effective and safe treatment option for different types of warts. However, there are few studies that illustrate the use of these antigens in the treatment of periungua...

Oct 3rd, 2019 - What is already known about this topic? Measles was eliminated in the United States in 2000. High national coverage with measles, mumps, and rubella vaccine and rapid implementation of measles control measures prevent widespread measles transmiss...

Apr 14th, 2019 - Measles, Also Known As Rubeola, Is A Highly Contagious Airborne Viral Illness That Infects Approximately Nine Out Of Ten Exposed Susceptible Individuals. Measles Infection Was Common Until The Measles, Mumps, And Rubella (MMR) Vaccine Was Licensed...

Mar 14th, 2019 - Mumps is a viral illness caused by a paramyxovirus, a member of the Rubulavirus family. The average incubation period for mumps is 16 to 18 days, with a range of 12 to 25 days.

Mar 6th, 2018 - The Advisory Committee on Immunization Practices made relatively few new vaccine recommendations in 2017. One pertained to prevention of hepatitis B virus infection in infants born to HBV-infected mothers. Another recommended a new vaccine to prev...

Mar 9th, 2017 - Immunity to a disease is achieved through the presence of antibodies to that disease in a person’s system. Antibodies are proteins produced by the body to neutralize or destroy toxins or disease-carrying organisms. Antibodies are disease-specific....

Feb 18th, 2021 - Mumps is classified as a class C infection disease in China, and the Chongqing area has one of the highest incidence rates in the country. We aimed to establish a prediction model for mumps in Chongqing and analyze its seasonality, which is import...

Feb 5th, 2021 - Background: Currently, children aged 6-9 years have the highest incidence rate of mumps in China. Although China has introduced a two-dose schedule of measles-mumps-rubella vaccine into routine immunization (at 8 months and 18 months), the inciden...

Feb 3rd, 2021 - Intralesional immunotherapy has been effectively used in the treatment of warts; however, comparative studies between different antigens are limited. To evaluate the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine co...

Feb 1st, 2021 - In a previous cohort study of 4-year-old Danish children, revaccination with the live measles-mumps-rubella vaccine (MMR) was associated with a 16% reduction in the rate of hospitalization lasting two days or longer for non-measles-mumps-rubella i...

Jan 28th, 2021 - Intralesional immunotherapy using different types of antigens is considered an effective and safe treatment option for different types of warts. However, there are few studies that illustrate the use of these antigens in the treatment of periungua...

Dec 27th, 2020 - NEW YORK (Reuters Health) - Many children under age two did not receive the measles-mumps-rubella (MMR) vaccine or preventive care visits even after clinics reopened following pandemic-related closures in a multicenter primary care network. The mo...

Dec 14th, 2020 - After an initial drop at the time of introduction of social distancing measures in March 2020, hexavalent (DTaP/IPV/Hib/HepB) and measles, mumps and rubella (MMR) vaccination counts have almost reached pre-COVID-19 levels, according to the latest ...

Nov 22nd, 2020 - (Reuters) - People whose immune systems responded strongly to a measles-mumps-rubella (MMR) vaccine may be less likely to become severely ill if they are infected with the new coronavirus, new data suggest. The MMR II vaccine, manufactured by Merc...

May 18th, 2020 - FILE PHOTO: A vial of measles, mumps and rubella vaccine and an information sheet is seen at Boston Children's Hospital in Boston, Massachusetts February 26, 2015. REUTERS/Brian Snyder/File Photo (Reuters) - Researchers have documented a drop in c...

Feb 13th, 2020 - You may have recently seen articles about a skin cream that could protect against infection from mosquito-borne viruses, commutes exposing drivers to harmful chemicals in car seats, and how researchers used gene sequencing to link seemingly separa...